Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study


Por: Mercader-García P, Pastor-Nieto MA, García-Doval I, Giménez-Arnau A, González-Pérez R, Fernández-Redondo V, Serra-Baldrich E, Cordoba-Guijarro S, Gatica-Ortega ME, Silvestre J and GEIDAC¶

Publicada: 1 ene 2018
Resumen:
Background. Corticosteroids are among the most commonly used topical drugs. Contact allergy to these exists, but can be easily missed. Corticosteroid screening markers have been included in the baseline series with the aim of detecting most of the sensitized patients. Objectives. To assess the prevalence of contact allergy to topical corticosteroids in Spain and examine the usefulness of corticosteroid markers to detect contact allergy to corticosteroids. Methods. In total, 3699 patients referred to 20 dermatology departments across Spain for patch testing with the baseline series, including budesonide and tixocortol pivalate, were also tested with six supplementary corticosteroids (methylprednisolone aceponate, mometasone furoate, prednicarbate, clobetasol propionate, betamethasone 17-valerate, and betamethasone 17,21-dipropionate). Additionally, 2547 (68.8%) patients were tested with hydrocortisone 17-butyrate. Results. Fifty-four patients showed positive reactions to at least one of all tested corticosteroids (1.46%). Thirty-nine (1.05%) reacted to at least one of the additionally tested corticosteroids; among these, 24 of 39 (61.5%) did not react to any of the corticosteroid allergy screening markers tested. Conclusions. More than half of the patients who were allergic to the additionally tested corticosteroids were not detected with the corticosteroid allergy markers. An update of the corticosteroid allergy screening markers is encouraged, with consideration of group 3 corticosteroids.

Filiaciones:
Mercader-García P:
 Dermatology Department, Hospital General Universitario Jose Mª Morales Meseguer, 30008, Murcia, Spain

Pastor-Nieto MA:
 Dermatology Department, Hospital Universitario de Guadalajara, 19002, Guadalajara, Spain

García-Doval I:
 Unidad de Investigación of the Fundación Piel Sana AEDV of the Spanish Academy of Dermatology, 28008, Madrid, Spain

Giménez-Arnau A:
 Dermatology Department, Hospital del Mar, 08003, Barcelona, Spain

González-Pérez R:
 Dermatology Department, Hospital Universitario de Araba, 01009, Vitoria-Gasteiz, Spain

Fernández-Redondo V:
 Dermatology Deparment, Hospital Gil-Casares, 15706, Santiago de Compostela, Spain

Serra-Baldrich E:
 Dermatology Deparment, Hospital Sant Pau, 08025, Barcelona, Spain

Cordoba-Guijarro S:
 Dermatology Deparment, Hospital Universitario de Fuenlabrada, 28942, Madrid, Spain

Gatica-Ortega ME:
 Dermatology Deparment, Complejo Hospitalario Virgen del Valle, 45071, Toledo, Spain

Silvestre J:
 Dermatology Department, Hospital General de Alicante, 03010, Alicante, Spain
ISSN: 01051873





CONTACT DERMATITIS
Editorial
WILEY-BLACKWELL, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 78 Número: 1
Páginas: 76-82
WOS Id: 000418445900011
ID de PubMed: 28960334

MÉTRICAS